Clinical trial · Interventional
The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer
Single-blinded, Randomized, Controlled Trial About the Effects of n-3 LCPUFAs on Weight and Functional Status in Patients With Colorectal Cancer.
NCT04699760CI-TRIAL-00049305completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine the effects of n-3 PUFAs on weight, physical funktion and quality of life in patients with colorectal cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Cachexia | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
| Side Effects | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fish Oil | Dietary Supplement | — | UNRESOLVED |
| Placebo | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Nutritional supplement without fish oil
- interventionNames
- Dietary Supplement: Placebo
- type
- ACTIVE_COMPARATOR
- label
- Fish oil
- description
- Nutritional supplement with fish oil
- interventionNames
- Dietary Supplement: Fish Oil
Primary outcomes (1)
- measure
- Weight loss
- timeFrame
- 8 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * ≥18 years * Patients with diagnosed colorectal cancer with metastases treated with chemotherapy on Rigshospitalet, Copenhagen Exclusion Criteria: * \< 18 years * Patients in palliative care * patients with haemophilia * Patiens in treatment of anti-coagulation * Patients with genetic hyperkolesterolemia * Pre-dialytic patients (GFR\<15ml/min/1,73m2 eller kreatinin ≥500 mmol/L)
References
Publications (0)
Data not yet available
No reference posted for this study.